Stanford University
Showing 11,301-11,350 of 13,059 Results
-
Nelson Teng
Professor of Obstetrics and Gynecology (Oncology), Emeritus
Current Research and Scholarly InterestsGynecologic Malignancies
Immunotherapy
Biologic Response Modifiers
New Drug Development
Antigenic specificities of human antibodies encoded by the VH4-34 gene -
Valerie Teng
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Valerie Teng is a board certified family physician with special interests in preventative medicine and women's health. Her experiences in caring for patients with chronic conditions, such as diabetes and hypertension, have fueled her desire to partner with patients to enter healthier lifestyles. She is also passionate about providing comprehensive care to patients of all ages, including newborns and teens.
During her residency training, Dr. Teng explored many opportunities in medical education through the O’Connor-Stanford Leaders in Education Residency (OSLER) program. She is delighted to continue in medical education as a part of the faculty at Stanford Family Medicine. -
Azusa Terasaki
Postdoctoral Scholar, Pathology
BioAzusa Terasaki, MD, PhD, is a Postdoctoral scholar in the Department of Pathology at Stanford University School of Medicine. Her research focuses on tumor immunology and cancer metabolism, with a particular interest in mitochondrial transfer between cancer and immune cells and its role in immune suppression and metastasis.
Dr. Terasaki received her medical degree and PhD in Japan, where she completed her surgical training and is a board-certified surgeon with additional certifications as a breast specialist and in cancer therapy. During her clinical career, she developed a strong interest in translational research that bridges fundamental discoveries and patient care.
Her current work investigates how cancer cells reprogram immune cells through organelle transfer, integrating imaging, flow cytometry, and multi-omic approaches to uncover novel mechanisms of tumor–immune interaction. Her goal is to identify new therapeutic targets and biomarkers to improve cancer treatment outcomes. -
Stefano Testa, MD
Instructor, Medicine - Oncology
BioDr. Stefano Testa is a board-certified, fellowship-trained medical oncologist with Stanford Health Care. He is also a clinical instructor in the Department of Medicine, Division of Oncology at Stanford University School of Medicine.
Dr. Testa specializes in treating patients with sarcomas and other solid tumors using cellular therapy approaches. He has expertise in adoptive T-cell therapies, including chimeric antigen receptor T-cell (CAR-T) and T-cell receptor (TCR) therapies.
As a physician-scientist, Dr. Testa focuses on developing next-generation cellular therapies for solid tumors, particularly sarcomas. His research goal is to identify targets for adoptive T-cell therapies in solid tumors, including soft tissue and bone sarcomas, and on novel synthetic biology approaches to enhance the effectiveness of T-cell therapies against solid tumors.
Dr. Testa has authored numerous peer-reviewed publications in leading medical journals, including Immunity, Cancer Discovery, JAMA Network Open, Genome Medicine, and Biomacromolecules. He has presented his research at national and international scientific meetings, including the Connective Tissue Oncology Society Annual Meeting and the Society for Immunotherapy of Cancer Annual Meeting.
Dr. Testa is a member of the American Society of Clinical Oncology (ASCO), Connective Tissue Oncology Society (CTOS), the American Society of Hematology (ASH), and the Society for Immunotherapy of Cancer (SITC). -
Jeffrey Teuteberg
Professor of Medicine (Cardiovascular Medicine)
BioHe is currently a Professor of Medicine at Stanford, but is no longer seeing patients as he is on leave and working with industry.
His research interests are in clinical outcomes in patients after transplant and mechanical support as well as novel approaches to immunosuppression. He has participated in many single-center and multi-institutional research studies and has published widely in the fields of transplant and mechanical support. He served as President of the International Society of Heart and Lung Transplantation in 2018. -
Winifred Teuteberg
Clinical Professor, Medicine - Primary Care and Population Health
BioDr. Teuteberg completed residency training in Internal Medicine at the University of Chicago and a Palliative Medicine Fellowship at Massachusetts General Hospital. She joined the faculty at Stanford in 2017 and currently sees patients as a part of the inpatient palliative care consult team at Stanford Healthcare.
She has been the clinical director or Stanford Medicine's implementation of the Ariadne Labs' Serious Illness Care Program since its inception in 2018. Her interests include communication skills training, leveraging predictive algorithms to identify patients who would most benefit from serious illness conversations, how to empower non-physician clinical team members to participate in this work, and best practice for EHR builds related to advance care planning. -
Haluk Tezcan, MD
Adjunct Clinical Associate Professor, Medicine - Oncology
BioClinical focus:
Breast Oncology
Molecular Diagnostics
Dr. Tezcan is a medical oncologist and hematologist with over three decades of diverse experience in cancer management and research.
He is leading the clinical development of Droplet Biosciences' novel liquid biopsy technology, a first-in-class lymphatic fluid molecular residual disease assessment, overseeing the scientific and clinical development of the technology. With over three decades of direct patient care and clinical trial experience as a principal investigator and director, both in academia and private practice, he has a firsthand understanding of the unmet clinical needs of physicians and patients, as well as broad experience in clinical trial design and implementation.
He is also co-principal at Athea Oncology, guiding practices and hospitals in developing clinical trial programs and high-value real-world data collection and diagnostic companies in clinical development. He is also a reviewer of JCO Precision Medicine.
Before joining Athea Oncology and Droplet Biosciences, he was the co-founder of LexentBio, which was successfully acquired by Roche/FMI. He also served as Director of Translational Medicine at Genomic Health and as Vice President, leading oncology development at Counsyl, where he integrated science with clinical product development. He established the CA.RE.foundation, a cancer research foundation dedicated to enabling the execution of clinical trials across community oncology sites throughout the Northwest US. He has independently built multiple software tools to help oncologists navigate the practical realities of their daily work. -
Sonoo Thadaney Israni
Executive Director, Presence + Program in Bedside Medicine, Med/Program/Bedside Med
Current Role at StanfordExecutive Director, Presence (med.stanford.edu/presence.html) & Program in Bedside Medicine/Stanford 25 (stanfordmedicine25.stanford.edu)
Instructor Stanford University School of Medicine - Authentic Courage for Constructive Change: Skills and Practice for Leadership
LinkedIn Profile: www.linkedin.com/in/sonoo/ -
Julie Ngoc Thai, MD, MPH
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Thai is a fellowship-trained specialist in geriatric medicine. She provides care at the Stanford Senior Care Clinic.
She completed her fellowship training at the University of California, San Francisco. She is board-certified in family medicine through the American Board of Family Medicine .
Dr. Thai earned her medical degree from Michigan State University College of Human Medicine. She completed her residency in family medicine at McLaren Flint/Michigan State University College of Human Medicine where she served as chief resident.
She also holds a Master of Public Health degree from Columbia University.
Dr. Thai has a background in clinical and population health research. She recently received a grant from the Blue Cross Blue Shield of Michigan Foundation to study the role of motivational interviewing in smoking cessation.
She contributed to research in rheumatoid arthritis, lupus, and ankylosing spondylitis in the Division of Rheumatology, Department of Medicine at Cedars Sinai Medical Center.
Dr. Thai was also an endourology research fellow in the Department of Urology at Mount Sinai Health System. Research focused on renal stone disease, clinical markers and outcomes, and testing and development of new technologies.
She has co-authored articles on topics such as caregivers’ communication with elders living with late-life disability, palliative care practices in diverse settings, and the social consequences of forgetfulness and Alzheimer’s disease. These articles appeared in the American Journal of Hospice and Palliative Medicine, Journal of Palliative Medicine, Journal of Mental Health Aging, and other peer-reviewed journals
Dr. Thai is a member of the American Geriatrics Society, American Academy of Family Physicians, and California Academy of Family Physicians. She is also an inductee of the Alpha Omega Alpha Honor Medical Society.
She has volunteered with homeless shelters, women’s advocacy groups, Goodwill, the American Red Cross, and AmeriCorps.
Dr. Thai is fluent in English and proficient in speaking Vietnamese. -
Christoph Thaiss
Associate Professor of Pathology
Current Research and Scholarly InterestsThe Thaiss Lab investigates how gut-brain interactions influence health and disease. By studying microbiome-host communication, the lab explores how microbial signals impact immune function, metabolism, and neurological health. Using multi-omic technologies and computational models, they aim to uncover mechanisms underlying inflammation, neurological disorders, and metabolic diseases. Their research supports the development of personalized therapies targeting the gut-brain axis.
-
Avnesh Thakor
Professor of Radiology (Pediatric Radiology)
Current Research and Scholarly InterestsInterventional Radiologists can access almost any part of the human body without the need for conventional open surgical techniques. As such, they are poised to change the way patients can be treated, given they can locally deliver drug, gene, cell and cell-free therapies directly to affected organs using image-guided endovascular, percutaneous, endoluminal, and even using device implantation approaches
-
Tristan Tham, MD
Assistant Professor of Otolaryngology - Head & Neck Surgery
BioDr. Tristan Tham is an Ear, Nose, and Throat (ENT) surgeon and Assistant Professor in the Department of Otolaryngology – Head & Neck Surgery at Stanford University School of Medicine.
Born and raised in Singapore, Dr. Tham earned his medical degree with honors from the Royal College of Surgeons, where he received the Norman Rae Gold Medal for academic excellence and thesis award. Following medical school, he began his career as a junior doctor at Singapore General Hospital, where he was honored with the ‘Heart of Gold’ Award for achieving the highest patient satisfaction ratings. He then pursued further research training at the New York Head & Neck Institute, where he was eventually promoted to Director of Patient-Oriented Research.
Dr. Tham completed his ENT surgery residency in New York City at the Manhattan Eye, Ear & Throat Hospital, Lenox Hill Hospital, and Long Island Jewish Medical Center. During his residency, he was selected for membership in the Alpha Omega Alpha Honor Medical Society.
As an ENT surgeon, Dr. Tham treats a wide range of head and neck disorders, including sinus issues and obstructive sleep apnea, cancers of the sinus cavity and salivary glands, thyroid and parathyroid disorders, head and neck tumors, and chronic ear conditions. He prioritizes a personalized approach to care, working closely with patients to develop individualized treatment plans that address their unique needs.
Dr. Tham's contributions to the medical field extend beyond his clinical practice. He has authored over 200 publications, abstracts, and presentations. He has also served as Associate Editor for Otolaryngology – Head & Neck Surgery, the official journal of the American Academy of Otolaryngology.
Beyond his work in the clinic, Dr. Tham is committed to giving back through pro bono efforts in underserved regions around the world. He has participated in multiple medical missions abroad, reflecting his dedication to making a difference beyond his practice.
When he's not at work, Dr. Tham enjoys reading, weightlifting, and exploring the beautiful nature of Northern California with his wife and children. -
Swaraj Thaman
Life Science Research Professional, Pediatrics - Endocrinology
Current Role at StanfordLife Science Research Professional 1, Translational Genomics of Diabetes Laboratory, Department of Pediatrics - Endocrinology, School of Medicine
-
CASSANDRA THANH
Clinical Assistant Professor, Medicine
BioOriginally from Southern California, Dr. Cassy Thanh moved to the Bay Area for her undergraduate studies at UC Berkeley, where she majored in Rhetoric and Molecular/Cell Biology. She subsequently worked in translational HIV research in San Francisco, followed by pursuing her medical education at UC San Francisco while continuing infectious diseases research. She completed her Internal Medicine residency at UC San Diego in 2026 before returning to the Bay Area to start her new chapter as an academic hospitalist at Stanford. Her professional passions include providing high-quality care across diverse settings, identifying and addressing health inequities, and advancing medical education. Outside of the hospital, she is a proud parent, avid reader, and milk tea enthusiast.
-
Suzanne Tharin
Associate Professor of Neurosurgery
Current Research and Scholarly InterestsThe long-term goal of my research is the repair of damaged corticospinal circuitry. Therapeutic regeneration strategies will be informed by an understanding both of corticospinal motor neuron (CSMN) development and of events occurring in CSMN in the setting of spinal cord injury. MicroRNAs are small, non-coding RNAs that regulate the expression of “suites” of genes. The work in my lab seeks to identify microRNA controls over CSMN development and over the CSMN response to spinal cord injury.
-
Kate Therkelsen, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Therkelsen is a board-certified, fellowship-trained neuro-oncologist with the Stanford Medicine Cancer Center and a clinical assistant professor in the Department of Neurology and Neurological Sciences.
She diagnoses and treats a wide range of conditions including primary brain tumors and cancers of the central nervous system, metastatic disease to the brain and spinal cord, and neurologic complications of cancer. She prepares a personalized, comprehensive care plan for each patient she serves.
Dr. Therkelsen’s research interests include clinical trials of new therapeutics, as well as ways to reduce toxicities that some patients may experience when receiving cancer treatment. Her fellowship research projects included a study of survival and long-term function among patients treated for primary central nervous system lymphoma. She also received a pre-doctoral National Institutes of Health Intramural Research Training Award for her work with the Framingham Heart Study.
She has published in Current Treatment Options in Oncology and other peer-reviewed journals. She has presented to her peers at international, national, and regional meetings, including the annual meetings of the Society of Neuro-Oncology and of the American Academy of Neurology.
Dr. Therkelsen is a member of the Society of Neuro-Oncology and the American Academy of Neurology. -
Hawa Racine Thiam
Assistant Professor of Bioengineering and of Microbiology and Immunology
Current Research and Scholarly InterestsOur current work has two branches. Branch #1 is building a quantitative and predictive understanding of how neutrophils initiate and complete NETosis. Branch #2 is identifying the molecular and biophysical mechanisms that regulate high deformability in neutrophils. These branches converge onto understanding and harnessing the impact of nuclear biophysics on immune cell functions to re-engineer neutrophils for improved health.
